Claudin18.2, a shining star in gastric cancer, Transcenta’s TST001 stands at the global forefront
HONG KONG, Sep 28, 2022 – (ACN Newswire via SEAPRWire.com) – Transcenta Holding Limited (06628.HK), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of […]